EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Deferred Versus Performed Revascularization for Left Main Coronary Disease With Hemodynamic Significance

Takayuki Warisawa iD, Christopher M Cook iD, Yousif Ahmad iD, James P Howard iD, Henry Seligman iD, Christopher Rajkumar iD, Takumi Toya iD, Shunichi Doi, Akihiro Nakajima, Masafumi Nakayama iD, Rafael Vera-Urquiza iD, Sonoka Yuasa und 11 weitere

Circulation: Cardiovascular Interventions · 2023

DOI: 10.1161/circinterventions.122.012700 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2023. Verfasst von Takayuki Warisawa und 22 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki, Japan (T.W., S.D., Y.J.A.). Hauptthemen laut MEDLINE: Coronary Artery Disease, Myocardial Infarction, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The majority of randomized controlled trials of revascularization decision-making excludes left main coronary artery disease (LMD). Therefore, contemporary clinical outcomes of patients with stable coronary artery disease and LMD with proven ischemia remain poorly understood. The aim of this study was to assess the long-term clinical outcomes of physiologically significant LMD according to the treatment strategies of revascularization versus revascularization deferral.

Methods

In this international multicenter registry of stable LMD interrogated with the instantaneous wave-free ratio, patients with physiologically significant ischemia (instantaneous wave-free ratio ≤0.89) were analyzed according to the coronary revascularization (n=151) versus revascularization deferral (n=74). Propensity score matching was performed to adjust for baseline clinical characteristics. The primary end point was a composite of death, nonfatal myocardial infarction, and ischemia-driven target lesion revascularization of left main stem. The secondary end points were as follows: cardiac death or spontaneous LMD-related myocardial infarction; and ischemia-driven target lesion revascularization of left main stem.

Results

At a median follow-up period of 2.8 years, the primary end point occurred in 11 patients (14.9%) in the revascularized group and 21 patients (28.4%) in the deferred group (hazard ratio, 0.42 [95% CI, 0.20–0.89]; P =0.023). For the secondary end points, cardiac death or LMD-related myocardial infarction occurred significantly less frequently in the revascularized group (0.0% versus 8.1%; P =0.004). The rate of ischemia-driven target lesion revascularization of left main stem was also significantly lower in the revascularized group (5.4% versus 17.6%; hazard ratio, 0.20 [95% CI, 0.056–0.70]; P =0.012).

Conclusions

In patients who underwent revascularization for stable coronary artery disease and physiologically significant LMD determined by instantaneous wave-free ratio, the long-term clinical outcomes were significantly improved as compared with those in whom revascularization was deferred.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseMyocardial InfarctionPercutaneous Coronary InterventionHumansTreatment OutcomeCoronary Artery BypassMyocardial RevascularizationDeath

Stichwörter der Autor:innen

coronary physiologydeferralinstantaneous wave-free ratioischemialeft main coronary artery diseaserevascularization

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki, Japan (T.W., S.D., Y.J.A.).
  • Department of Cardiology, NTT Medical Center Tokyo, Japan (T.W.).
  • National Heart and Lung Institute, Imperial College London, UK (T.W., J.P.H., H.S., C.R., Y.K., R.A.-L., S.S., J.E.D.).
  • The Essex Cardiothroacic Centre, UK (C.M.K.).
  • Anglia Ruskin University, Essex, UK (C.M.K.).
  • Cardiovascular Medicine, Yale School of Medicine, New Haven, CT (Y.A.).

ORCID-Profile: Takayuki Warisawa, Christopher M Cook, Yousif Ahmad, James P Howard, Henry Seligman, Christopher Rajkumar, Takumi Toya, Masafumi Nakayama, Rafael Vera-Urquiza, Takao Sato, Hidetaka Nishina, Rasha Al-Lamee, Amir Lerman, Hitoshi Matsuo, Yoshihiro J Akashi, Javier Escaned

Förderung

  • British Heart Foundation

Zitieren

APA

Warisawa, T., Cook, C. M., Ahmad, Y., Howard, J. P., Seligman, H., Rajkumar, C., Toya, T., Doi, S., Nakajima, A., Nakayama, M., Vera-Urquiza, R., Yuasa, S., Sato, T., Kikuta, Y., Kawase, Y., Nishina, H., Al-Lamee, R., Sen, S., Lerman, A., …, & Davies, J. E. (2023). Deferred Versus Performed Revascularization for Left Main Coronary Disease With Hemodynamic Significance. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.122.012700

Vancouver

Warisawa T, Cook CM, Ahmad Y, Howard JP, Seligman H, Rajkumar C, et al. Deferred Versus Performed Revascularization for Left Main Coronary Disease With Hemodynamic Significance. Circulation: Cardiovascular Interventions. 2023. doi:10.1161/circinterventions.122.012700

BibTeX
@article{Warisawa2023,
  author = {Warisawa, Takayuki and Cook, Christopher M and Ahmad, Yousif and Howard, James P and Seligman, Henry and Rajkumar, Christopher and Toya, Takumi and Doi, Shunichi and Nakajima, Akihiro and Nakayama, Masafumi and Vera-Urquiza, Rafael and Yuasa, Sonoka and Sato, Takao and Kikuta, Yuetsu and Kawase, Yoshiaki and Nishina, Hidetaka and Al-Lamee, Rasha and Sen, Sayan and Lerman, Amir and Matsuo, Hitoshi and Akashi, Yoshihiro J and Escaned, Javier and Davies, Justin E},
  title = {Deferred Versus Performed Revascularization for Left Main Coronary Disease With Hemodynamic Significance},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2023},
  doi = {10.1161/circinterventions.122.012700}
}
Kostenlos starten →